Canadian Biopharma Stock Jumps on Clinical Trial

BELLUS Health Inc. (TSX:BLU), a Canadian biopharma stock, rose after completing patient enrollment for the RELIEF trial

Sean Mason | March 19, 2020 | SmallCapPower

A Phase 2 trial update pushed a Canadian biopharma stock higher Thursday. Here’s some small stocks making big moves on Thursday, March 19, 2020 (as of 11:30 am EST):

BELLUS Health Inc. (TSX:BLU), a Canadian biopharma stock, climbed 21% to $11.40 on Thursday after announcing that it has completed patient enrollment for the RELIEF trial, its dose-escalation, placebo-controlled Phase 2 trial of BLU-5937 in patients with refractory chronic cough.

Win Big With Our Small Cap Picks


As well, shares of SunOpta Inc. (TSX:SOY) surged 34% to $3.07 as the organic foods and ingredients provider said it expects its first-quarter 2020 Adjusted EBITDA to double year over year to a range of between $21 million to $25 million.

Reliq Health Technologies Inc. (TSXV:RHT), meanwhile, reported that it continues to provide the full range of iUGO Care software solutions and services to its clients remotely and its clients are able to use the iUGO Care platform to communicate virtually with their patients, monitor patients’ existing chronic conditions, evaluate patients for symptoms of COVID-19 infection and document risk factors such as travel or exposure to anyone who has tested positive for the virus. Reliq Health Technologies stock moved up 38% to $0.31 following the announcement.

See more Small and Micro Cap Market Movers Daily from Sean Mason. Tomorrow’s big stock market winners could be found here today!

Hi, did you know SmallCapPower accepts blog submissions? You can contact me here

Disclosure: Neither the author nor his family own shares in any of the companies mentioned above.

To read our full disclosure, please click on the button below: